Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia

被引:36
|
作者
Steele, Amy [1 ]
Gonzalez, Ramon [2 ]
Garbalosa, Juan C. [3 ]
Steigbigel, Keith [3 ]
Grgurich, Tania [2 ]
Parisi, Erika J. [5 ]
Feinn, Richard S. [1 ]
Tommasini, Steven M. [4 ]
Macica, Carolyn M. [1 ]
机构
[1] Quinnipiac Univ, Frank H Netter MD Sch Med, Dept Med Sci, North Haven, CT 06518 USA
[2] Quinnipiac Univ, Sch Hlth Sci, Dept Diagnost Imaging, North Haven, CT 06518 USA
[3] Quinnipiac Univ, Sch Hlth Sci, Dept Phys Therapy, North Haven, CT 06518 USA
[4] Quinnipiac Univ, Sch Med, Yale Univ, Dept Orthopaed, New Haven, CT 06510 USA
[5] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
关键词
X-linked hypophosphatemia; range of motion; gait analysis; enthesopathy; degenerative arthritis; osteophyte; PEX GENE; PHOSPHATE; THERAPY; RICKETS; PREVALENCE; MOTION; RELIABILITY; KINEMATICS; RANGE; TRUNK;
D O I
10.1210/clinem/dgaa064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: X-Linked hypophosphatemia (XLH) is a lifelong metabolic disease with musculoskeletal comorbidities that dominate the adult clinical presentation. Objective: The adult XLH disorder has yet to be quantified on the basis of the physical and functional limitations that can affect activities of daily living. Our goal was to report the impact of the musculoskeletal manifestations on physical function. Design and setting: Musculoskeletal function was evaluated by validated questionnaires and in an interdisciplinary clinical space where participants underwent full-body radiologic imaging, goniometric range of motion (ROM) measurements, general performance tests, and kinematic gait analysis. Patients: Nine adults younger than 60 years with a diagnosis of XLH and self-reported musculoskeletal disability, but able to independently ambulate, were selected to participate. Passive ROM and gait analysis were also performed on age-approximated controls to account for differences between individual laboratory instrumentation. Results: Enthesophytes, degenerative arthritis, and osteophytes were found to be consistently bilateral and diffusely present at the spine and synovial joints across participants, with predominance at weight-bearing joints. Passive ROM in adults with XLH was decreased at the cervical spine, hip, knee, and ankle compared to controls. Gait analysis relative to controls revealed increased step width, markedly increased lateral trunk sway, and physical restriction at the hip, knees, and ankle joints that translated into limitations through the gait cycle. Conclusions: The functional impact of XLH musculoskeletal comorbidities supports the necessity for creating an interprofessional health-care team with the goal of establishing a longitudinal plan of care that considers the manifestations of XLH across the lifespan.
引用
收藏
页码:E1798 / E1814
页数:17
相关论文
共 50 条
  • [41] Factors associated with impaired physical functionality in X-linked hypophosphatemia
    Ivanovic-Zuvic, Danisa
    Madison, Annette
    Jimenez, Macarena
    Oyanadel, Maria L.
    Gattini, Natalia
    Guzman, Carolina
    Cifre, Manuela
    Silvestre, Rony
    Garcia, Cristian
    Contreras, Oscar
    Collins, Michael T.
    Florenzano, Pablo
    JBMR PLUS, 2025, 9 (04)
  • [42] Dental health of patients with X-linked hypophosphatemia: A controlled study
    Larsson, Amila
    Regnstrand, Tobias
    Skott, Pia
    Makitie, Outi
    Bjornsdottir, Sigridur
    Garming-Legert, Karin
    FRONTIERS IN ORAL HEALTH, 2023, 4
  • [43] Hypertension is a characteristic complication of X-linked hypophosphatemia
    Nakamura, Yoshie
    Takagi, Masaki
    Takeda, Ryojun
    Miyai, Kentaro
    Hasegawa, Yukihiro
    ENDOCRINE JOURNAL, 2017, 64 (03) : 283 - 289
  • [44] Impact of X-Linked Hypophosphatemia on Muscle Symptoms
    Romagnoli, Cecilia
    Iantomasi, Teresa
    Brandi, Maria Luisa
    GENES, 2022, 13 (12)
  • [45] Iron and fibroblast growth factor 23 in X-linked hypophosphatemia
    Imel, Erik A.
    Gray, Arnie K.
    Padgett, Leah R.
    Econs, Michael J.
    BONE, 2014, 60 : 87 - 92
  • [46] A Novel Synonymous Variant of PHEX in a Patient with X-Linked Hypophosphatemia
    Ma, Xiaosen
    Pang, Qianqian
    Zhang, Qi
    Jiang, Yan
    Wang, Ou
    Li, Mei
    Xing, Xiaoping
    Xia, Weibo
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (06) : 634 - 640
  • [47] Office Blood Pressure and Obesity in Children with X-Linked Hypophosphatemia
    Boeckmann, Ineke
    Leifheit-Nestler, Maren
    Rehberg, Mirko
    Sparta, Giuseppina
    Evers, Katrina
    Schlingmann, Karl Peter
    Kemper, Markus J.
    Richter-Unruh, Annette
    Hiort, Olaf
    Grohmann-Held, Karina
    Derichs, Ute
    Freiberg, Clemens
    Weitz, Marcus
    Dunstheimer, Desiree
    Schmid, Elmar
    John-Kroegel, Ulrike
    Metzing, Oliver
    Heger, Sabine
    Jorch, Norbert
    Staude, Hagen
    Patzer, Ludwig
    Wuehl, Elke
    Zivicnjak, Miroslav
    Schnabel, Dirk
    Haffner, Dieter
    CALCIFIED TISSUE INTERNATIONAL, 2025, 116 (01) : 56
  • [48] Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy
    Orlando, Giorgio
    Roy, Matthew
    Bubbear, Judith
    Clarke, Shane
    Keen, Richard
    Javaid, Muhammad Kassim
    Ireland, Alex
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (11) : 2055 - 2060
  • [49] Novel variants and uncommon cases among southern Chinese children with X-linked hypophosphatemia
    Lin, Y.
    Xu, J.
    Li, X.
    Sheng, H.
    Su, L.
    Wu, M.
    Cheng, J.
    Huang, Y.
    Mao, X.
    Zhou, Z.
    Zhang, W.
    Li, C.
    Cai, Y.
    Wu, D.
    Lu, Z.
    Yin, X.
    Zeng, C.
    Liu, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (11) : 1577 - 1590
  • [50] Reassuring Data on the Cardiovascular Risk in Adults With X-linked Hypophosphatemia Receiving Conventional Therapy
    Bouzemane, Alexandre
    Vignot, Emmanuelle
    Derain Dubourg, Laurence
    De Mul, Aurelie
    Molin, Arnaud
    Chapurlat, Roland
    Fontanges, Elisabeth
    Delsart, Daphne
    Akbari, Alirea
    Huang, Shih Han Susan
    Mcintyre, Christopher W.
    Bacchetta, Justine
    Lemoine, Sandrine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (02) : e488 - e494